Clearline Capital LP Ironwood Pharmaceuticals Inc Transaction History
Clearline Capital LP
- $2.27 Billion
- Q3 2024
A detailed history of Clearline Capital LP transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Clearline Capital LP holds 92,870 shares of IRWD stock, worth $367,765. This represents 0.02% of its overall portfolio holdings.
Number of Shares
92,870
Previous 92,870
-0.0%
Holding current value
$367,765
Previous $605,000
37.02%
% of portfolio
0.02%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding IRWD
# of Institutions
236Shares Held
162MCall Options Held
11.2MPut Options Held
9.1K-
Black Rock Inc. New York, NY22.9MShares$90.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA22MShares$87.3 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$64.9 Million16.75% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.3MShares$44.7 Million0.11% of portfolio
-
State Street Corp Boston, MA9.92MShares$39.3 Million0.0% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $607M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...